Skip to main content
Signal8
Launch Terminal

Azora Therapeutics, Inc. (AZR)

Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.

Industry: Medical - Pharmaceuticals

Azora Therapeutics, Inc. logo

Azora Therapeutics, Inc.

NASDAQ:AZRHealthcare
Pre+4.20%$3.97
Close$5.05+36.12%
Mkt Cap$13.26M
Float1.66M
O/S2.63M
Vol
$ Vol
RVOL
Inst Own-
SI10.8%
Earnings
Dilution
Azora Therapeutics, Inc. logoNASDAQ:AZRPre$3.97+4.20%
FormDescription
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
3
Initial Statement of Beneficial Ownership
8-K
CURRENT REPORT
5
EFFECT
Notice of Effectiveness
1
10-Q/A
AMENDMENT NO. 1 TO FORM 10-Q
7
S-3/A
AMENDMENT NO. 1 TO FORM S-3
6
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
3
8-K
CURRENT REPORT
2
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
2
8-K
CURRENT REPORT
1
4
Statement of Changes in Beneficial Ownership
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
5
8-K
CURRENT REPORT
5
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
5
8-K
CURRENT REPORT
5
S-3
REGISTRATION STATEMENT
7
S-8
REGISTRATION STATEMENT
2
8-K
CURRENT REPORT
2
ARS
SEC Filing
DEF 14A
PROXY STATEMENT
8
8-K
CURRENT REPORT
4
8-K
CURRENT REPORT
6
10-Q
QUARTERLY REPORT
7
8-K
CURRENT REPORT
4

1-25 of 571

…